BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Péneau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, Paradis V, Blanc JF, Letouzé E, Nault JC, Amaddeo G, Zucman-Rossi J. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut 2022;71:616-26. [PMID: 33563643 DOI: 10.1136/gutjnl-2020-323153] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 42.0] [Reference Citation Analysis]
Number Citing Articles
1 Yun B, Ahn SH, Oh J, Yoon J, Kim BK. Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.10.026] [Reference Citation Analysis]
2 Teboul R, Grabias M, Zucman-rossi J, Letouzé E. Discovering cryptic splice mutations in cancers via a deep neural network framework.. [DOI: 10.1101/2022.10.14.512264] [Reference Citation Analysis]
3 Zhao L, Wang Y, Tian T, Rao X, Dong W, Zhang J, Yang Y, Tao Q, Peng F, Shen C, Wang S, Liu H, Zeng X, Zhou W. Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Hepatol Int 2022. [PMID: 36123506 DOI: 10.1007/s12072-022-10419-3] [Reference Citation Analysis]
4 Wang G, Chen Z. HBV Genomic Integration and Hepatocellular Carcinoma. Advanced Gut & Microbiome Research 2022;2022:1-7. [DOI: 10.1155/2022/2140886] [Reference Citation Analysis]
5 Zhuo H, Fan J, Zhang B, Shi Y, Zheng L, Chai Y, Yao L. Association of gallstone and polymorphisms of UGT1A1*27 and UGT1A1*28 in patients with hepatitis B virus-related liver failure. Open Medicine 2022;17:1455-1465. [DOI: 10.1515/med-2022-0549] [Reference Citation Analysis]
6 Xiang Z, Li J, Lu D, Wei X, Xu X. Advances in multi-omics research on viral hepatitis. Front Microbiol 2022;13:987324. [DOI: 10.3389/fmicb.2022.987324] [Reference Citation Analysis]
7 Salpini R, D’anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 2022;13:972687. [DOI: 10.3389/fmicb.2022.972687] [Reference Citation Analysis]
8 Lin J, Jia P, Wang S, Ye K. Comparison and benchmark of long-read based structural variant detection strategies.. [DOI: 10.1101/2022.08.09.503274] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen Y, Wu F, Wu P, Xing H, Ma T. The Role of The Tumor Microbiome in Tumor Development and Its Treatment. Front Immunol 2022;13:935846. [DOI: 10.3389/fimmu.2022.935846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 . HCC: Karzinogene Effekte einer Integration von HBV-DNA nachverfolgt. Z Gastroenterol 2022;60:896-8. [DOI: 10.1055/a-1795-5747] [Reference Citation Analysis]
11 Zhuravleva E, O'Rourke CJ, Andersen JB. Mutational signatures and processes in hepatobiliary cancers. Nat Rev Gastroenterol Hepatol 2022;19:367-82. [PMID: 35273358 DOI: 10.1038/s41575-022-00587-w] [Reference Citation Analysis]
12 Koffas A, Mak L, Gill US, Kennedy PTF. Early Treatment Consideration in Patients with Hepatitis B ‘e’ Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift? Viruses 2022;14:900. [DOI: 10.3390/v14050900] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pollicino T. The Impact of Nucleos(t)ide Analogs on Hepatitis B Virus DNA Integration: Hype or Reality? Gastroenterology 2022;162:1030-3. [PMID: 35120915 DOI: 10.1053/j.gastro.2022.01.039] [Reference Citation Analysis]
14 Hsu YC, Suri V, Nguyen MH, Huang YT, Chen CY, Chang IW, Tseng CH, Wu CY, Lin JT, Pan DZ, Gaggar A, Podlaha O. Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation. Gastroenterology 2022;162:1160-1170.e1. [PMID: 34995536 DOI: 10.1053/j.gastro.2021.12.286] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
15 An J, Kim D, Oh B, Oh YJ, Song J, Park N, Kim HI, Kang HJ, Oh JH, Kim W, Lee E, Sung CO, Song GW, Kim DG, Yu E, Letouzé E, Zucman-Rossi J, Lee HC, Shim JH. Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas. Hepatology 2022;75:997-1011. [PMID: 34478159 DOI: 10.1002/hep.32135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Dias JD, Sarica N, Cournac A, Koszul R, Neuveut C. Crosstalk between Hepatitis B Virus and the 3D Genome Structure. Viruses 2022;14:445. [PMID: 35216038 DOI: 10.3390/v14020445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chen Z, He X. Application of third-generation sequencing in cancer research. Medical Review 2021;1:150-171. [DOI: 10.1515/mr-2021-0013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang S, Lin J, Yang X, Li Z, Tun X, Wang T, Wang B, Hu L, Ye K. Long read sequencing reveals sequential complex rearrangements driven by Hepatitis B virus integration.. [DOI: 10.1101/2021.12.09.471697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Oropeza CE, Ondracek CR, Tarnow G, Maienschein-Cline M, Green SJ, McLachlan A. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns. Virology 2022;566:16-25. [PMID: 34844082 DOI: 10.1016/j.virol.2021.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Álvarez EG, Demeulemeester J, Otero P, Jolly C, García-Souto D, Pequeño-Valtierra A, Zamora J, Tojo M, Temes J, Baez-Ortega A, Rodriguez-Martin B, Oitaben A, Bruzos AL, Martínez-Fernández M, Haase K, Zumalave S, Abal R, Rodríguez-Castro J, Rodriguez-Casanova A, Diaz-Lagares A, Li Y, Raine KM, Butler AP, Otero I, Ono A, Aikata H, Chayama K, Ueno M, Hayami S, Yamaue H, Maejima K, Blanco MG, Forns X, Rivas C, Ruiz-Bañobre J, Pérez-Del-Pulgar S, Torres-Ruiz R, Rodriguez-Perales S, Garaigorta U, Campbell PJ, Nakagawa H, Van Loo P, Tubio JMC. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture. Nat Commun 2021;12:6910. [PMID: 34824211 DOI: 10.1038/s41467-021-26805-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
21 Kaczmarek R, Pierce GF, Noone D, O'Mahony B, Page D, Skinner MW. Eliminating Panglossian thinking in development of AAV therapeutics. Mol Ther 2021:S1525-0016(21)00569-4. [PMID: 34758292 DOI: 10.1016/j.ymthe.2021.10.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Zhuo Z, Rong W, Li H, Li Y, Luo X, Liu Y, Tang X, Zhang L, Su F, Cui H, Xiao F. Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma. NPJ Genom Med 2021;6:84. [PMID: 34642322 DOI: 10.1038/s41525-021-00245-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Dalwadi DA, Calabria A, Tiyaboonchai A, Posey J, Naugler WE, Montini E, Grompe M. AAV integration in human hepatocytes. Mol Ther 2021;29:2898-909. [PMID: 34461297 DOI: 10.1016/j.ymthe.2021.08.031] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 17.0] [Reference Citation Analysis]
24 Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol 2021:S0168-8278(21)02099-7. [PMID: 34624411 DOI: 10.1016/j.jhep.2021.09.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
25 Choi WM, Yip TC, Lim YS, Wong GL, Kim WR. Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments. J Hepatol 2021:S0168-8278(21)02079-1. [PMID: 34592365 DOI: 10.1016/j.jhep.2021.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Wang Y, Tong Y, Zhang Z, Zheng R, Huang D, Yang J, Zong H, Tan F, Xie Y, Huang H, Zhang X. ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects. Nucleic Acids Res 2021:gkab779. [PMID: 34500462 DOI: 10.1093/nar/gkab779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Midorikawa Y, Tatsuno K, Moriyama M. Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: Insights next generation sequencing. Hepatobiliary Surg Nutr 2021;10:548-52. [PMID: 34430541 DOI: 10.21037/hbsn-21-228] [Reference Citation Analysis]
28 Rachakonda S, Hoheisel JD, Kumar R. Occurrence, functionality, and abundance of the TERT promoter mutations.. [DOI: 10.1101/2021.05.03.442397] [Reference Citation Analysis]
29 Zhang D, Zhang K, Protzer U, Zeng C. HBV Integration Induces Complex Interactions between Host and Viral Genomic Functions at the Insertion Site. J Clin Transl Hepatol 2021;9:399-408. [PMID: 34221926 DOI: 10.14218/JCTH.2021.00062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
30 Péneau C, Zucman-Rossi J, Nault JC. Genomics of Viral Hepatitis-Associated Liver Tumors. J Clin Med 2021;10:1827. [PMID: 33922394 DOI: 10.3390/jcm10091827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Garcia-Garcia S, Cortese MF, Rodríguez-Algarra F, Tabernero D, Rando-Segura A, Quer J, Buti M, Rodríguez-Frías F. Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects. Expert Rev Mol Diagn 2021;21:381-96. [PMID: 33880971 DOI: 10.1080/14737159.2021.1913055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Álvarez EG, Demeulemeester J, Jolly C, García-souto D, Otero P, Pequeño A, Zamora J, Tojo M, Temes J, Baez-ortega A, Rodríguez-martín B, Li Y, Oitaben A, Bruzos AL, Martínez-fernández M, Haase K, Santamarina M, Zumalave S, Abal R, Rodríguez-castro J, Rodriguez-casanova A, Diaz-lagares A, Raine K, Butler AP, Ono A, Aikata H, Chayama K, Ueno M, Hayami S, Yamaue H, Blanco MG, Forns X, Rivas C, Pérez-del-pulgar S, Torres-ruiz R, Rodríguez Perales S, Garaigorta U, Nakagawa H, Campbell PJ, Van Loo P, Tubio JMC. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.. [DOI: 10.1101/2021.04.19.440412] [Reference Citation Analysis]
33 Zeisel MB, Guerrieri F, Levrero M. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. J Clin Med 2021;10:1715. [PMID: 33923385 DOI: 10.3390/jcm10081715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Fujiwara K. Novel Genetic Rearrangements in Hepatitis B Virus: Complex Structural Variations and Structural Variation Polymorphisms. Viruses 2021;13:473. [PMID: 33809245 DOI: 10.3390/v13030473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pollicino T, Caminiti G. HBV-Integration Studies in the Clinic: Role in the Natural History of Infection. Viruses 2021;13:368. [PMID: 33652619 DOI: 10.3390/v13030368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]